Powered by proprietary data and machine learning, our platform is an end-to-end platform built for RNA drug discovery.

From target/structure discovery to chemical optimisation, our platforms enables discovery and optimisation of selective small molecules modulating RNA function, such as translational or splicing.
‍
Orion: An RNA Atlas:  The world’s largest dataset for experimentally determined, functional RNA structures. 
Orion is currently 50,000+ experimentally determined druggable RNA structures covering key cancer drivers and undruggable targets for immunology (eg: c-MYC, STATs, NFkb).

Polaris: A GenAI platform to design molecules unconstrained by the human mind.
A GenAI chemistry platform trained on proprietary data, Polaris generates selective, small molecules that modulate RNA function. Our GenAI platform is proven to design molecules not designed by human-medicinal chemists and outperforms state-of-the-art methods such as NVIDIA MolMIMM for RNA-small molecules.

Ara: A "kinome panel for RNA".  
‍Ara is an in-cell chemi-transcriptomics screening platform, ensuring the discovery of selective, functional small molecules targeting RNA.